Diabetes Medication
The first treatment for type 2 diabetes blood glucose (sugar) control is often meal planning, weight loss, and exercising. Sometimes these measures are not enough to bring blood glucose levels down near the normal range. The next step is taking a medicine that lowers blood glucose levels.
All diabetes pills sold today are members of six classes of drugs that work in different ways to lower blood glucose levels:
- Sulfonylureas
- Meglitinides
- Biguanides
- Thiazolidinediones
- Alpha-glucosidase inhibitors
- DPP-4 inhibitors
Sulfonylureas
Sulfonylureas stimulate the beta cells of the pancreas to release more insulin. Sulfonylurea drugs have been in use since the 1950s. Chlorpropamide (Diabinese) is the only first-generation sulfonylurea still in use today. The second generation sulfonylureas are used in smaller doses than the first-generation drugs. There are three second-generation drugs: glipizide (Glucotrol and Glucotrol XL), glyburide (Micronase, Glynase, and Diabeta), and glimepiride (Amaryl). These drugs are generally taken one to two times a day, before meals. All sulfonylurea drugs have similar effects on blood glucose levels, but they differ in side effects, how often they are taken, and interactions with other drugs.
Meglitinides
Meglitinides are drugs that also stimulate the beta cells to release insulin. Repaglinide (Prandin) and nateglinide (Starlix) are meglitinides. They are taken before each of three meals.
Because sulfonylureas and meglitinides stimulate the release of insulin, it is possible to have hypoglycemia (low blood glucose levels).
You should know that alcohol and some diabetes pills may not mix. Occasionally, chlorpropamide, and other sulfonylureas, can interact with alcohol to cause vomiting, flushing, or sickness. Ask your doctor if you are concerned about any of these side effects.
Biguanides
Metformin (Glucophage) is a biguanide. Biguanides lower blood glucose levels primarily by decreasing the amount of glucose produced by the liver. Metformin also helps to lower blood glucose levels by making muscle tissue more sensitive to insulin so glucose can be absorbed. It is usually taken two times a day. A side effect of metformin may be diarrhea, but this is improved when the drug is taken with food.
Thiazolidinediones
Rosiglitazone (Avandia) and pioglitazone (ACTOS) are in a group of drugs called thiazolidinediones. These drugs help insulin work better in the muscle and fat and also reduce glucose production in the liver. The first drug in this group, troglitazone (Rezulin), was removed from the market because it caused serious liver problems in a small number of people. So far rosiglitazone and pioglitazone have not shown the same problems, but users are still monitored closely for liver problems as a precaution. Both drugs appear to increase the risk for heart failure in some individuals, and there is debate about whether rosiglitazone may contribute to an increased risk for heart attacks. Both drugs are effective at reducing A1C and generally have few side effects.
Alpha-glucosidase inhibitors
Acarbose (Precose) and meglitol (Glyset) are alpha-glucosidase inhibitors. These drugs help the body to lower blood glucose levels by blocking the breakdown of starches, such as bread, potatoes, and pasta in the intestine. They also slow the breakdown of some sugars, such as table sugar. Their action slows the rise in blood glucose levels after a meal. They should be taken with the first bite of a meal. These drugs may have side effects, including gas and diarrhea.
DPP-4 Inhibitors
A new class of medications called DPP-4 inhibitors help improve A1C without causing hypoglycemia. They work by by preventing the breakdown of a naturally occuring compound in the body, GLP-1. GLP-1 reduces blood glucose levels in the body, but is broken down very quickly so it does not work well when injected as a drug itself. By interfering in the process that breaks down GLP-1, DPP-4 inhibitors allow it to remain active in the body longer, lowering blood glucose levels only when they are elevated. DPP-4 inhibitors do not tend to cause weight gain and tend to have a neutral or positive effect on cholesterol levels. Sitagliptin (Januvia) and saxagliptin (Onglyza) are the two DPP-4 inhibitors currently on the market.
Oral combination therapy
Because the drugs listed above act in different ways to lower blood glucose levels, they may be used together. For example, a biguanide and a sulfonylurea may be used together. Many combinations can be used. Though taking more than one drug can be more costly and can increase the risk of side effects, combining oral medications can improve blood glucose control when taking only a single pill does not have the desired effects. Switching from one single pill to another is not as effective as adding another type of diabetes medicine.
Related article: Diabetes Basics
官網:www.baichuan365.com | 微信服務號:iseebio | 微博:seebiobiotech |
商城:mall.seebio.cn | 微信訂閱號:seebiotech | 泉養堂:www.canmedo.com |
相關資訊
- Nissui日水EEM肉湯培養基
- 癌抗原 CYFRA21-1
- Cell:揭示巨噬細胞吞噬死亡細胞產生分子記憶機制
- 分泌型磷脂酶A2
- 標準品CRM和對照品RM區別
- 重大發現!當再生大量骨骼時,骨骼肌干細胞返回到一種更加原始的細胞類型
- 西寶生物 - ISO45001職業健康安全管理認證證書
- Nature:脂肪酸控制骨骼干細胞再生
- 西寶生物 Miragen - 代理證書
- 研究人員發現治療黑色素瘤的新靶點
新進產品
同類文章排行
- FUJIFILM Wako 內毒素檢測相關問題答疑
- 聚乙二醇主鏈ELISA試劑盒使用說明書
- 如何使用抗-PEG瓊脂糖親和純化mPEG-BSA
- 為什么使用了wako的PVSK滴定溶液(貨號167-28105,替代164-21655),測陽離子電荷密度的結果和原先有偏差
- 凝膠滲透色譜法的驗證
- 有關分子量的若干問題 - 一個已知聚合物樣品其分子量是什么?
- 纖維素內切酶T片劑(T-CTZ)可以替代羧甲基纖維素(CMC)用于不同來源的纖維素酶檢測嗎?
- 化學試劑的純度與分級標準
- 【技術問答】Ludger DMB唾液酸釋放標記試劑盒問題集錦
- 纖維素內切酶T片劑(T-CTZ)能用于牛仔布洗滌工序中纖維素酶活性的精確測定嗎?